CURRICULUM VITAE
Mohammed Al-Omran, MD, MSc, FRCSC
Personal Data
Place and date of Birth: Riyadh, Saudi Arabia on October 28/1970
Marital status: married
Hobbies: Scuba diving, Soccer
Languages: English, Arabic
Contact Information: P.O.Box 1474
Riyadh, 11431
Saudi Arabia
Telephone (+966) 55-688-5887
Fax (+9661) 467-9493
m_alomran@hotmail.com
Qualifications
1995
M.B; B.S. (Medical Doctor Degree)
King Saud University(KSU), Riyadh, Saudi Arabia
(First Class Honors- GPA 4.6/5)
2001
Master of Science
Clinical Epidemiology and Health Care Research,
University of Toronto
2003
Canadian Board of General Surgery
Specialist Certificate of the Royal College of Physicians and Surgeons of
Canada in General Surgery
2003
Clinical Investigator Certificate
The Royal College of Physicians and Surgeons of Canada
2005
Canadian Board of Vascular Surgery
Specialist Certificate of the Royal College of Physicians and Surgeons of
Canada in Vascular Surgery
1
Training
April 1995 to March 1996
Internship
Major teaching hospitals in Riyadh, Saudi Arabia
April 1996 to March 1997
Surgical Demonstrator
The Faculty of Medicine, King Saud University
Involved in the research activities and teaching
July 1997 to June 2003
Residency
General Surgery Program, University of Toronto
July 1999 to June 2001
Clinical Investigator and Surgical Scientists Programs
Department of Surgery and Clinical Epidemiology and Health
Care Research Program, University of Toronto
The Institute for clinical Evaluative Science (ICES),
Toronto, Ontario
July 2003 to June 2005
Fellowship
Vascular Surgery Program, University of Toronto
Academic Appointments

Assistant Professor, Department of Surgery, King Saud University, Riyadh,
Saudi Arabia, October 3, 2005- Present

Director for the Research Program, Division of Vascular Surgery, King Saud
University, Riyadh, Saudi Arabia, October 3, 2005- Present

Associate Director for the Postgraduate Medical Education, College of
Medicine, King Saud University, Riyadh, Saudi Arabia, April 21, 2007- Present.

Chair, Postgraduate Training Programs Board, College of Medicine, King
Saud University, Riyadh, Saudi Arabia, April 21, 2007- Present.

Research Program Chair, Department of Surgery, King Saud University,
Riyadh, Saudi Arabia, December 5, 2006- Present.

Member, College of Medicine Research Center, King Saud University,
Riyadh, Saudi Arabia, May 5, 2007- Present
2

Program Director for the Fellowship Program, Division of Vascular Surgery,
King Saud University, Riyadh, Saudi Arabia, December16, 2006- Present

Member, Medical Education Board, King Saud University, Riyadh, Saudi
Arabia, April 21, 2007- Present

Secretary General of Postgraduate Training Board, College of Medicine, King
Saud University, Riyadh, Saudi Arabia, December 10, 2005- April 20, 2007.

Deputy Associate Director of the Postgraduate Medical Education Programs,
College of Medicine, King Saud University, Riyadh, Saudi Arabia, December 10,
2005- April 20, 2007.
Hospital Appointments

Staff Vascular Surgeon, King Fahad Medical City, Riyadh, Saudi Arabia,
March 1, 2006- Present

Staff Vascular Surgeon, King Khalid University Hospital, Riyadh, Saudi Arabia,
October 3, 2005- Present

Staff Vascular Surgeon, Toronto General Hospital, University of Toronto,
Toronto, Canada, August 1,2005-September 30, 2005
Memberships

Fellow of the Royal College of Surgeons of Canada.

Member of the College of Physicians and Surgeons of Ontario.

Member of the Canadian Medical Protective Association.

Member of the Canadian Medical Association.

Member of the Canadian Society for Vascular Surgery.

Member of the Saudi Council for Health Specialties.

Member of the Saudi Society for Vascular Surgery.
3
Awards
1995 Riyadh Governer’s Certificate of Excellence for outstading performance
in the medical school.
1996 KSU-Faculty of Medicine Dean’s Certificate of Excellence for outstanding
performance in the internship.
1998-2005 Saudi Cultural Bureau in Canada academic awards
2005 AAGL, Kurt Semm Award
Scientific Committees & Professional Activities

Saudi Society for Vascular surgery Executive Committee
Treasurer and Research Committee Chair, February 26, 2006- Present

Atherosclerosis risk reduction program, Saudi Society for Vascular Surgery
Chair, August 15, 2006- Present

The National Scientific Evidence-Based Medicine Committee (NSEBMC)
Member, July 8, 2006- Present

Medical Education Research and Publication Committee, Medical Education
Center, King Saud University
Member, December 19, 2005- Present

Non-Clinical Skills Development and Improvement Committee, Medical
Education Center, King Saud University
Member, January 1, 2006- Present

Implementation of the new Medical School Curriculum Committee, Medical
Education Center, King Saud University
Member, December 2, 2005- Present

Member of the Organizing Committee for the 11th Vascular Anastomosis
Workshop, Riyadh, Saudi Arabia, December 14-15, 2005

Member of the Organizing Committee for 6th Doppler Applications Course,
Riyadh, Saudi Arabia, December 17, 2005

Member of the Organizing Committee for 2nd Basic and 1st Advanced
Endovascular Course, Riyadh, Saudi Arabia, February23-24, 2006
4

Member of the Organizing Committee for the 6th International Symposium on
Vascular Surgery, Riyadh, Saudi Arabia, February 26-27, 2006

Member of the Organizing Committee for the Critical Appraisal of the
Medical Literature Workshop, King Fahad Medical City, Riyadh, Saudi
Arabia, March 21-22, 2006

Member of the Organizing Committee for the 6th Annual Surgical Research
Conference , King Khalid University Hospital, Riyadh, Saudi Arabia, April
27, 2006

Co-Chair of the Organizing Committee for the 1st GCC Evidence-Based
Clinical Practice Workshops, Riyadh, Saudi Arabia, November 4-8, 2006

Member of the Organizing Committee for 3rd Vascular Duplex Course,
Riyadh, Saudi Arabia, November 11-14, 2006

Member of the Organizing Committee for the 12th Vascular Anastomosis
Workshop, Riyadh, Saudi Arabia, December 5-7, 2006

Member of the Organizing Committee for the 1st Advanced Vascular
Anastomosis Workshop, Riyadh, Saudi Arabia, December 9, 2006

Member of the Organizing Committee for the 1st Carotid Stenting
Workshop, Riyadh, Saudi Arabia, December 16-17, 2006

Member of the Organizing Committee for the 1st Endovenous Laser
Therapy Workshop, Riyadh, Saudi Arabia, February 20, 2007

Chair of the Organizing Committee for the 6th Surgical Research Intensive
Course, King Khalid University Hospital, Riyadh, Saudi Arabia, January 18,
2007.

Strategic Planning for the College of Medicine and University Hospitals
Committee, King Saud University
Member, February 3, 2007- Present

Chair of the Organizing Committee for the 1st scientific conference of the
Saudi Society for Vascular Surgery, Jeddah, Saudi Arabia, March 1, 2007.

Co-Chair of the Organizing Committee for the 2nd GCC Evidence-Based
Clinical Practice Workshops, Riyadh, Saudi Arabia, March 17-21, 2007.
5

Chair of the Organizing Committee for the 7th Annual Surgical Research
Conference , King Khalid University Hospital, Riyadh, Saudi Arabia, April
26, 2007

The University Diabetic Center Executive Committee, King Saud University
Member, March 13, 2007- Present

Systematic Review and Randomized Clinical Research Center committee, King
Saud University
Member, May 5, 2007- Present

Chair of the Scientific Committee for the 1st Towards Evidence-Based
Practice Workshop, King Fahad Medical City, Riyadh, Saudi Arabia, June
6, 2007.

Interview Committee for the Unified Admission Exam for Health Sciences
Colleges , King Saud University
Member, July 1, 2007- Present

Co-Chair of the Organizing Committee for the 13th Vascular Anastomosis
Workshop, Riyadh, Saudi Arabia, October 24-25, 2007

Co-Chair of the Organizing Committee for the 3rd GCC Evidence-Based
Clinical Practice Workshops, Riyadh, Saudi Arabia, December 1-5, 2007.

Chair of the Organizing Committee for the Postgraduate Medical Education
Graduation Day, King Saud University Riyadh, Saudi Arabia, December 5,
2007.

Chair of the Organizing Committee for the 2nd scientific conference of the
Saudi Society for Vascular Surgery, Riyadh, Saudi Arabia, January 20-21,
2008.
Research Experience

Research Fellow at the Institute for clinical Evaluative Science (ICES), Toronto,
Ontario from July1999 to June 2001.

Founder of the Laparoscopy and Hysteroscopy databases at the Department of
Obstetric and Gynecology, University of Western Ontario in conjunction with Drs
Abu-Rafea and Vilos GA, 2003

Co- Investigator: the Systemic Assessment of Vascular Risk (SAVR) program at
the University Health Network, University of Toronto, 2004.
6

Principal Investigator: the ‘Risk Reduction in Vascular Patients’ Project at the
Institute for clinical Evaluative Science (ICES), Toronto, 2005

Principal Investigator: Prevalence of and Risk Factors for Peripheral Arterial
Disease in Saudi Arabia: A Multicenter National Survey, 2005

Founder of the Peripheral Arterial Disease and Carotid Artery Disease databases
at the Division of Vascular Surgery, King Saud University, 2005

Principal Investigator: Visfatin, A novel visceral fat peptide and its role in PAD:
Investigating the adipo-vascular axis, 2006

Principal Investigator: Role of Rosiglitazone, a PPAR- γ agonist in development
of collateral circulation, in rabbit models of hind limb ischemia , 2006

Co- Investigator: The role of Agmantine in intimal hyperplasia in response to
vascular injury, 2006

Founder of the AtherothromboSis Risk ReducTion TAsk FoRce in Saudi Arabia
(STAR), 2006
Research Grants and Contracts
1) King Abdulaziz City for Science and Technology: “Role of Rosiglitazone, a
PPAR- γ agonist in development of collateral circulation, in rabbit models of hind
limb ischemia”
$150,000 (PI, 2006-2008)
2) King Saud University, College of Medicine Research Center: “Visfatin, A novel
visceral fat peptide and its role in PAD: Investigating the adipo-vascular axis”
$20,000 (PI, 2006-2007)
3) King Saud University, College of Medicine Research Center: “The role of
Agmantine in intimal hyperplasia in response to vascular injury”
$15,000 (Co-Investigator, 2006-2007)
4) Sanofi-Aventis: “The Role of Ankle Brachial Index in Predicting Acute Coronary
Syndrome: A Population-Based Study”
$75,000 (PI, 2006-2008)
5) Sanofi-Aventis: “Atherothrombosis Risk Reduction Task Force in Saudi Arabia
(STAR program)”
$50,000 (PI, 2006-2008)
7
Publications
Master’s thesis

Utilization and Outcomes of Interventional Procedures for Peripheral Arterial
Occlusive Disease in Ontario: A Population-based Study. (2001)
Supervisors: Dr. Jack V. Tu, Dr. Daryl Kucey and Dr. K.Wayne Johnston.
Peer-Reviewed Journals
1) Al-Rikabi AC, Al-Omran M, Cheema M, El-Khwsky F, Al-Nuaim A. Pattern of
thyroid lesions and role of fine needle aspiration cytology (FNA) in the
management of thyroid enlargement: a retrospective study from a teaching
hospital in Riyadh. APMIS 1998; 106:1069-74.
2) Al-Omran M, Kucey DS. Intravascular Lipoma of the Left Common Femoral
Vein. J Vasc Surg 2001;33:1104-7.
3) Al-Omran M, Groof A, Wilke D. Enteral versus parenteral nutrition for acute
pancreatitis. In: The Cochrane Library, Issue 2, 2001.
4) Al-Omran M, Mamdani M, McLeod R. Epidemiological features of Acute
Appendicitis in Ontario, Canada. Can J Surg 2003; 46:263-8.
5) Al-Omran M, Tu JV, Mamadani M, Johnston KW, Kucey DS. Outcome of
Revascularization Procedures for Peripheral Arterial Occlusive Disease in Ontario
between 1991 and 1998: A Population-based Study. J Vasc Surg 2003;38:279-88.
6) Al-Omran M, Tu JV, Johnston KW, Mamadani M, Kucey DS. Use of
Interventional Procedures for Peripheral Arterial Occlusive Disease in Ontario
between 1991 and 1998: A Population-based Study. J Vasc Surg 2003 ;38:28995.
7) Wang CH, Ciliberti N, Li SH, Szmitko PE, Weisel RD, Fedak PW, Al-Omran M,
Cherng WJ, Li RK, Stanford WL, Verma S. Rosiglitazone Facilitates Angiogenic
Progenitor Cell Differentiation Toward Endothelial Lineage: A New Paradigm in
Glitazone Pleiotropy. Circulation 2004; 109:1392-400.
8) Al-Omran M, Sternbach Y. Lower Limbs Critical Ischemia. Geriatrics and
Aging 2004; 7: 49-54.
9) Alwahbi A, Al-Omran M, Aro L, Ameli FM. Do we need blood transfusion in
elective infrarenal abdominal aortic aneurysm repair. Saudi Med J. 2004;
25:1762-3.
8
10) Al-Omran M, Verma S, Lindsay TF, Weisel RD, Sternbach Y. Clinical Decision
Making for Endovascular Repair of Abdominal Aortic Aneurysm. Circulation
2004; 110: e517-523.
11) AlKhenizan A, Al-Omran M. The Role of Vitamin E in the Prevention of
Coronary events and Stroke; Meta-analysis of Randomized Controlled`Trials.
Saudi Med J. 2004; 25: 1808-1814.
12) Al-Omran M, Lindsay TF. Should all patients with Peripheral Arterial Disease
be treated with an Angiotensin Converting Enzyme Inhibitor? Can J Cardio
2005; 21: 189-193.
13) AlKhenizan A, Al-Omran M. The Role of Vitamin E in the Prevention of
Coronary events and Stroke. Neurosceinces. 2005; 10: 23-29.
14) Abu-Rafea B,Vilos GA,Vilos AG, Ahmad R,Hollett-Caines J, Al-Omran M.
High-Pressure Laparoscopic Entry Does Not Adversely Affect Cardiopulmonary
Function In Healthy Women. J Minim Invasive Gyneco 2005; 12:475-479.
15) Vilos A.G; Vilos G.A; Al-Omran M; Hollett-Caines J; Abu-Rafea B. Effect of
Body Habitus and Parity on the Initial Veres Intraperitoneal CO(2) Insufflation
Pressure during Laparoscopic Access in Women. J Minim Invasive Gyneco.
2006; 13:108-113.
16) Abu-Rafea B; Vilos G.V; Vilos A.G; Hollett-Caines J; Al-Omran M. Effect Of
Body Habitus And Parity On Insufflated C02 Volume At Various IntraAbdominal Pressures During Laparoscopic Access In Women. J Minim Invasive
Gyneco. 2006; 13:205-210.
17) Al-Omran M, , Lindsay TF, Major J, Jawas A, Verma S. Perception of Canadian
Vascular Surgeon towards Pharmacological Risk Reduction in Patients with
Peripheral Arterial Disease. Annals of Vasc Surg 2006; 20(5):555-63.
18) Al-Khayal K, Al-Omran M. Computed Tomography versus Ultrasonography in
the diagnosis Equivocal Acute Appendicitis: A Systematic Review. Saudi Med J
2007; 28(2):173-80.
19) Al-Sheaik S, Aljabri B, Al-Ansary L, Al-Khayal L, Al-Salman M, Al-Omran M.
Prevalence of and Risk Factors for Peripheral Arterial Disease in Saudi Arabia: A
Pilot Cross-Sectional Study. Saudi Med J 2007; 28(3):412-4.
20) Al-Omran M. True Ulnar Artery Aneurysm of the Hand in an 18-month old Boy:
A Case Report. J Vasc Surg 2007; 45(4):841-43.
9
21) Verma S, Mamdani MM, Al-Omran M, Melo M, Rouleau JL. Angiotensin
Receptor Blockers versus Angiotensin Converting Enzyme Inhibitors and Acute
Coronary Syndrome Outcomes in Elderly Patients: A Population-Based Cohort
Study (UMPIRE Study Results). Journal of the American Society of
Hypertension 2007; 1:286-94.
22) Al-Omran M. Cardiovascular Death in Peripheral Arterial Disease: The Critical
Role of ACE Inhibitor Therapy. Journal of Vascular Health and Risk
Management 2007 (In Press).
23) Al-Omran M. Knowledge and Attitude of Physicians in a Major Teaching
Hospital towards Atherosclerotic Risk Reduction Therapy in patients with
Peripheral Arterial Disease. Journal of Vascular Health and Risk Management
2007 (In Press).
24) Al-Omran M, Lindsay TF. Outlook Commentary on the REACH registry.
Perspectives in Vascular Surgery and Endovascular Therapy 2007 (In Press).
25) Aljabri B, Al-Saleeh A, Al Sheikh S, Al-Tuwaijri T, Al-Habib K, Al-Omran M.
Peripheral Arterial Disease Evaluation in the Saudi Project for Assessment of
Coronary Events Registry reveals a Missed Opportunity in Preventing the adverse
Cardiovascular Outcomes: A Pilot Study (SPACE-PAD-I). Clinical Medicine:
Cardiology 2007 (In Press).
Manuscripts Submitted to Peer-Reviewed Journals
1) Al-Omran M, Mamdani MM, Lindsay TF, Verma S. Suboptimal use of Statins
Therapy in 343,154 Patients with Symptomatic Atherosclerosis: A Populationbased Study. (Submitted to JVS .
2) Al-Omran M, Jawas A, Major J, Verma S, Lindsay TF. Risk Reduction in
Patients with Peripheral Arterial Disease: Where Do We Stand? (Submitted to
Annals of Vascular Surg)
Manuscripts in preparation
1) Singh S, Al-Omran M, Ameli FM. Incisional Hernia after Abdominal Aortic
Surgery.
2) Al-Omran M, Alwahbi A, Aro L, Hicken G, Ameli FM. A prospective study
evaluating Aortobifemoral bypass outcomes: 11 years experience.
3) Aljabri B, Al-Omran M. Perception of Physicians in Saudi Arabia towards Risk
Reduction Therapy in Patients with Peripheral Arterial Disease Compared to
Coronary Artery Disease.
10
4) Al-Falih K, Al-Omran M. Reporting and Methodologic Quality of Cochrane
Neonatal Review Group Systematic Reviews.
5) Aljabri B, Al-Tuwaijri, Al-Salikh K, Al-Omran M. Endovenous Laser Therapy
for Varicose Veins: A Single Institute Experience.
6) El-Eter E, Al-Tuwaijiri T, Aljabri B, Al Sheikh S, Al-Salman M, Al-Omran M.
Does Visfatin Correlates with the Severity of Peripheral Arterial Disease in
Diabetic Patients?
7) El-Bakry A, Abu Alnasr T, Al-Omran M. Delayed Presentation of a Carotid
Artery Large Traumatic Aneurysm: A Case Report.
8) Al-Salikh K, Al-Omran M. The use of Thrombin Injection in the treatment of a
Radial Artery Psudoaneurysm: A Case Report.
Abstracts and Presentation
1) Al-Omran M, Alwahbi A, Aro L, Hicken G, Ameli FM. A prospective study
evaluating Aortobifemoral bypass outcomes: 11 years experience.
Presented at the 22nd annual meeting of the Canadian Soceity for Vascular
Surgery, Banff, Canada ,Septemberr 2000.
& Presented at the 5th annual Terrence Donnelly Cardiac and Vascular Residents’ Research
Day, May 2001
2) Alwahbi A, Al-Omran M, Aro L, Ameli FM. Do we need blood transfusion in
elective repair of infrarenal Abdominal Aortic Aneurysm?
Presented at the 22nd annual meeting of the Canadian Soceity for Vascular
Surgery, Banff, Canada ,Septemberr 2000.
3) Al-Omran M, Mamdani M, McLeod R. The Epidemiology of Acute Appendicitis
in Ontario, Canada.
Presented at the Department of Health Administration’s Research Day ,Toronto, Canada,
April 2001.
4) Al-Omran M, Groof A, Wilke D. Enteral versus parenteral nutrition for acute
pancreatitis.
Presented at the 21st annual assembly of General Surgeons and Residents ,Toronto, Canada
May 2001.
5) Al-Omran M, Mamdani M, McLeod R. Seasonal variation of Acute
Appendicitis. Clin Invest Med 2001; 24(4):224
Presented at the CSCI/CIHR Young Investigators’ Forum , Ottawa, Canada, September 2001
11
6) Al-Omran M, Kucey DS, Mamdani M, Johnston KW, Tu JV. Outcomes of
Revascularization Procedures for Peripheral Arterial Occlusive Disease in Ontario
between 1991 and 1998: A Population-based Study.
Presented at the 23rd annual meeting of the Canadian Soceity for Vascular
Surgery, Ottawa, Canada ,October 2001.
7) Al-Omran M, Kucey DS, Mamdani M, Johnston KW, Tu JV. Utilization of
Interventional Procedures for Peripheral Arterial Occlusive Disease in Ontario
between 1991 and 1998: A Population-based Study.
Presented at the 23rd annual meeting of the Canadian Soceity for Vascular
Surgery, Ottawa, Canada ,October 2001.
8) AlKhenizan A, Al-Omran M. The Role of Vitamin E in the Prevention of
Coronary events and Stroke; Meta-analysis of Randomized Controlled Trials.
Heart views 2004;4(4):11
9) Abu-Rafea B, Vilos GA, Vilos AG, Ahmad R, Hollett-Caines J,
Al-Omran M. High-Pressure Laparoscopic Entry Does Not Adversely
Affect Cardiopulmonary Function In Healthy Women.
Presented at the Global Congress of Gynecologic Endoscopy, AAGL 33rd annual meeting
Sansfransisco, CA, 2004.
10) Al-Omran M. Vascular Grafts Update.
Presented at the 2nd Winnipeg Vascular and Endovascular Symposium, Winnipeg,, Canada
April 2005.
11) Abu-Rafea B, Vilos GA, Vilos AG, Al-Omran M. Pneumoperitoneum
Hyper-Insufflation During Laparoscopic Entry is Safe.
Presented at the SOGC 61st ACM, Montreal, Canada, June 2005.
12) Abu-Rafea B, Vilos GA, Vilos AG, Al-Omran M. Impact of Body Habitus
& Parity on Laparoscopic Entry Guided by Veres Needle CO2 Insufflation
Pressure.
Presented at the SOGC 61st ACM, Montreal, Canada, June 2005.
13) Al-Omran M, , Lindsay TF, Leiter LA, Latter DA, Major J, Verma S. Canadian
Vascular Surgeon’s Perception towards Pharmacological Risk Reduction in
Patients with Peripheral Arterial Disease Identifying Glaring Knowledge and
Action Gaps.
Presented at the 27th annual meeting of the Canadian Soceity for Vascular
Surgery, Toronto, Canada, September 2005.
14) Al-Omran M, Jawas A, Major J, Verma S, Lindsay TF. Risk Reduction in
Patients with Peripheral Arterial Disease: Where Do We Stand?
Presented at the 27th annual meeting of the Canadian Soceity for Vascular
Surgery, Toronto, Canada, September 2005.
12
15) Al-Omran M, Mamdani MM, Lindsay TF, Verma S. Underutilization of Statins
Therapy in 343,154 Atherosclerotic Patients: A Population-based Study.
Presenaed at the 7th International Congress of the Asian Society for Vascular Surgery, Kuala
lumpur, Malaysia, August 2006.
16) Al-Sheaik S, Aljabri B, El-Kyali A, Al-Salman M, Al-Omran M. Prevalence of
and Risk Factors for Peripheral Arterial Disease in Saudi Arabia: A Pilot CrossSectional Study.
Presenaed at the 7th International Congress of the Asian Society for Vascular Surgery, Kuala
lumpur, Malaysia, August 2006.
& Presented at the 1st Scientific Meeting of the Saudi Society for Vascular Surgery,
Jeddah, Saudi Arabia, March 2007.
17) El-Eter E, Aljabri B, Al Sheikh S, Al-Tuwaijiri T, Al-Salman M, Al-Omran M.
Visfatin, a Novel Visceral Fat Peptide, Correlates with the Severity of Peripheral
Arterial Disease in Diabetic Patients: A Pilot Study
Presenaed at the 7th International Congress of the Asian Society for Vascular Surgery, Kuala
lumpur, Malaysia, August 2006.
& Presented at the 28th annual meeting of the Canadian Soceity for Vascular
Surgery, Calgary, Canada, September 2006.
& Presented at the 1st Scientific Meeting of the Saudi Society for Vascular Surgery, Jeddah, Saudi
Arabia, March 2007.
18) Aljabri B, Al-Omran M. Perception of Physicians in Saudi Arabia towards Risk
Reduction Therapy in Patients with Peripheral Arterial Disease Compared to
Coronary Artery Disease: A Pilot Study.
Presenaed at the 7th International Congress of the Asian Society for Vascular Surgery, Kuala
lumpur, Malaysia, August 2006.
& Presented at the 1st Scientific Meeting of the Saudi Society for Vascular Surgery,
Jeddah, Saudi Arabia, March 2007.
19) Nasser T, Aljabri B, El-Kyali A, Al-Salman M, Al-Omran M. In Patients With
Combined Carotid & Coronary Artery Disease: Should We Perform Synchronous
Procedures?
Presenaed at the 7th International Congress of the Asian Society for Vascular Surgery, Kuala
lumpur, Malaysia, August 2006.
20) Al-Omran M, Mamdani MM, Lindsay TF, Verma S. Underutilization of Statins
in Patients with Atherosclerosis: A Population-based Study.
Presened at the 28th annual meeting of the Canadian Soceity for Vascular
Surgery, Calgary, Canada, September 2006.
21) Aljabri B, Al-Tuwaijiri T, Al Sheikh S, Al-Salman M, Al-Omran M. Endovenous
Laser Therapy of the Great Saphenous Vein: Early Experience at King Khalid
University Hospital.
Presented at the 1st Scientific Meeting of the Saudi Society for Vascular Surgery, Jeddah, Saudi
Arabia, March 2007.
13
22) Al-Omran M., Aljabri B, Al-Saleh A, Al Sheikh S, Al-Tuwaijiri T, Al Habeeb K
Peripheral Arterial Disease Evaluation in the Saudi Project for Assessment of
Coronary Events Registry reveals a Missed Opportunity in Preventing the adverse
Cardiovascular Outcomes: A Pilot Study (SPACE-PAD-I)
Accepted for presentation at 8th International Congress of the Asian Society for Vascular Surgery,
Shangahi, China, November 2007.
23) Al-Omran M., Abu AlNasir T, Al-Salman M, Al Sheikh S, Al-Tuwaijiri T,
Aljabri B. Risk Reduction in Patients with Peripheral Arterial Disease in Saudi
Arabia: Where Do We Stand?
Accepted for presentation at 8th International Congress of the Asian Society for Vascular Surgery,
Shangahi, China, November 2007.
24) Al-Omran M., Al-Salman M, Al Sheikh S, Al-Zahrani H, Alwahbi A, Aljabri B.
Knowledge and Attitude of Physicians in Saudi Arabia towards Atherosclerotic
Risk Reduction Therapy in patients with Peripheral Arterial Disease.
Accepted for presentation at 8th International Congress of the Asian Society for Vascular Surgery,
Shangahi, China, November 2007.
25) El-Eter E, Al-Tuwaijiri T, Aljabri B, Al Sheikh S, Al-Salman M, Al-Omran M.
Does Visfatin Correlates with the Severity of Peripheral Arterial Disease in
Diabetic Patients?
Accepted for presentation at 8th International Congress of the Asian Society for Vascular Surgery,
Shangahi, China, November 2007.
26) Aljabri B, Al-Tuwaijiri T, Al Sheikh S, Al-Salman M, Al-Omran M. Endovenous
Laser Therapy of the Great Saphenous Vein: Early and Intermediate Results.
Accepted for presentation at 8th International Congress of the Asian Society for Vascular Surgery,
Shangahi, China, November 2007.
Invited Lectures & Presentations
1) 2nd Winnipeg Vascular and Endovascular Symposium, Winnipeg, Canada
April 2005.
Speaker (Vascular Graft Updates)
2) 6th Doppler Applications Course, Riyadh, Saudi Arabia, December 17, 2005
Speaker (Application of Doppler in the arterial System) and Instructor
3) 11th Vascular Anastomosis Workshop, Riyadh, Saudi Arabia, December 1415, 2005
Speaker (Patch Angioplasty) and Instructor
4) Research Skills Training Workshop, Riyadh, Saudi Arabia, February 9,
2006
Speaker (Study Design: The Basics) and Instructor
14
5) 7th Family Medicine Essentials Workshop: Update on Common Clinical
Problems and Practical Skills, Riyadh, Saudi Arabia, March 12-15, 2006
Speaker (Diabetic Foot and PAD)
6) 8th King Saud University Intensive Diabetes Course, Riyadh, Saudi Arabia,
March 4-15, 2006
Speaker (Diabetic Foot: A surgical Look)
7) 2nd Basic and Advanced Endovascular Course, Riyadh, Saudi Arabia,
February 23-24, 2006
Speaker (Renal Artery Angioplasty: The Controversies) and Instructor
8) Critical Appraisal of the Medical Literature Workshop, King Fahad Medical
City, Riyadh, Saudi Arabia, March 21-22, 2006
Speaker (How to Use an Article about a Diagnostic Test?) and Instructor
9) Surgical Update Symposium, Madinah, Saudi Arabia, April 3-5, 2006
Speaker (Diabetic Foot: The Basics)
(Atherosclerosis: A Surgical Look)
10) Surgical Update Symposium, Gurayat, Saudi Arabia, May 15-17, 2006
Speaker (Vascular Trauma Management)
(Atherosclerosis: A Surgical Look)
11) 3rd King Saud University Diabetic Foot Program, Riyadh, Saudi Arabia,
September 2-7, 2006
Speaker (Diabetic Vasculopathy)
(Surgical Procedures in managing Diabetic Foot)
12) From Knowledge to Action: EBM Across Health Care Specialties in Saudi
Arabia Conference, Riyadh, Saudi Arabia, September 6, 2006
Speaker (Evidence-Based Surgery: Limits and Solutions)
13) 6th International Vascular Surgery Symposium at the Saudi German
Hospital, Jeddah, Saudi Arabia, November 1-2, 2006
Speaker (Evidence-Based Approach for Risk Reduction in Patients with
Peripheral Arterial Disease)
14) 12th Vascular Anastomosis Workshop, Riyadh, Saudi Arabia, December 56, 2006
Speaker (Patch Angioplasty) and Instructor
15) 7th Doppler Applications Course, Riyadh, Saudi Arabia, December 9, 2006
Speaker (Application of Doppler in the arterial System) and Instructor
15
16) Systematic Review Course, National and Gulf Center for Evidence Based
Medicine, Riyadh, Saudi Arabia, December 20-21, 2006
Speaker and Instructor
17) 1st Endovenous Laser Therapy Workshop, Riyadh, Saudi Arabia, February
20, 2007
Speaker (EVLT Instruments and Technique) and Instructor
18) 19th Saudi Urology Meeting, Riyadh, Saudi Arabia, February 27, 2007
Speaker (How to practice Evidence Based Medicine in Urology)
19) 1st Scientific Meeting of the Saudi Society for Vascular Surgery, Jeddah,
Saudi Arabia, March 1, 2007
Speaker (Risk reduction in Patients with Peripheral Arterial Disease: What
is the Evidence?)
20) How to do a Systematic Review workshop, National and Gulf Center for
Evidence Based Medicine, Jeddah, Saudi Arabia, April 2-3, 2007
Speaker and Instructor
21) 3rd Saudi Evidence Based Medicine Conference, Jeddah, Saudi Arabia,
April 2-3, 2007
Speaker (Implementation of EBM in day to day activities: A Surgical
Perspective)
22) 3rd RKH- Evidence Based Medicine Workshop, Riyadh, Saudi Arabia, May
1-3, 2007
Speaker (Study Design and Level of Evidence)
23) Towards Evidence Based Practice workshop, Riyadh, Saudi Arabia, June 1,
2007
Speaker (Study Design and Level of Evidence)
(EBM: Limitations & Solutions)
24) 1st Scientific Conference on Laser and Cosmetic Technologies, Riyadh,
Saudi Arabia, June 6, 2007
Speaker (Endo Venous Laser Therapy: Technique and Outcomes)
Ongoing Research Projects
1) Al-Omran M, Aljabri B, Al-Wahbi A, Al-Salman MM. Prevalence of and Risk
Factors for Peripheral Arterial Disease in Saudi Arabia (A Multicenter National
Survey).
16
2) Al-Omran M, Lindsay TF, Verma S, Mamdani MM. Utilization of Risk
Reduction Pharmacotherapy in Patients with Atherosclerosis: A population-Based
Study.
3) Al-Omran M, Mamdani MM, Lindsay TF Verma S. Effect of Risk Reduction
Pharmacotherapy on the Outcomes of Interventional Procedures in Patients with
Peripheral Arterial Disease: A Population-Based Study.
4) Al-Omran M, Mamdani MM, Verma S, Lindsay TF. Effect of Risk Reduction
Pharmacotherapy on the Outcomes in Patients with Abdminal Aortic Aneurysm:
A Population-Based Study.
5) Al-Omran M, Aljabri B, Al-Habib K. The Role of Ankle Brachial Index in
Predicting Acute Coronary Syndrome: A Population-Based Study.
6) Al-Omran M, Aljabri B, Al-Sheaik S, El-Eter E, Verma S. The role of Visfatin in
the development and progression of PAD.
7) Al-Omran M, Aljabri B, El-Eter E, Al-Salman MM, Verma S. Role of
Rosiglitazone in the development of collateral circulation, in rabbit models of
hind limb ischemia.
8) Al-Omran M, El-Eter E, Al-Salman MM , Aljabri B. The role of Agmantine in
intimal hyperplasia in response to vascular injury.
17